Objective: To estimate the prevalence of NRTI and NNRTI drug resistance mutations in
patients failing NNRTI-based ART in Southern Africa. Study design: We conducted a …

Background The extent to which routinely collected HIV data from Zambia has been used in
peer-reviewed published articles remains unexplored. This paper is an analysis of peer …

Background HIV drug resistance (HIVDR) poses a threat to the HIV epidemic control in
Zambia especially in sub-populations such as the 15–24 years where there is poor …

Background: Lopinavir/Ritonavir (KaletraR) is a protease inhibitor used in the management
of HIV infection. The increased incidence of toxicity of antiretroviral therapy (ART) has …

Background Continued use of standardized, first-line ART containing NNRTIs and NRTIs
may contribute to ongoing emergence of HIV drug resistance (HIVDR) in Namibia. Methods …

Background: This study aimed to determine drug resistance mutations in patients with
virological failure and find correlation between HIV drug resistance test and viral load …

Background: Insufficient therapy during HIV-1 replication can promote the emergence of
drug-resistant strains, reduce the effectiveness of antiretroviral treatment (ART), and …

The human immunodeficiency virus (HIV) is a viral infection that destroys the human
immune system resulting in acquired immunodeficiency syndrome (AIDS). The Zambia HIV …

Since the initiation of Kenya's nationwide free antiretroviral therapy (ART) in 2003 and 3 by 5
initiatives the availability of highly active antiretroviral therapy (HAART) has increased …

Background According to the WHO, 38 million people suffer from HIV worldwide and
according to the HIV Drug Resistance Report, the prevalence of antiretroviral therapy (ART) …